|
Repligen Corp (NASDAQ: RGEN) |
|
Repligen Corp
RGEN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Repligen growth rates, revenue grew
by 10.44 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 677
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 11.44 %
Repligen's net income grew by 76.88 % in first quarter of 2025 year on year, above company average,
• More on RGEN's Growth
|
|
Repligen realized a net loss in trailing twelve months.
Repligen realized cash reduction of $ -1.47 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 11.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.95.
• More on RGEN's Valuation
|
|
|
|
|
Repligen realized net loss in trailing twelve months.
Repligen realized cash outflow of $ -1.47per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 11.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.95.
Repligen Price to Book Ratio is at 3.6 higher than Industry Avg. of -87993.38, and higher than S&P 500 Avg. of 0.01
• More on RGEN's Valuation
|
|
RGEN's Profitability Comparisons
|
Repligen achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in first quarter of 2025 to 3.89 %.
Repligen net profit margin of 3.45 % is currently ranking no. 16 in Biotechnology & Pharmaceuticals industry, ranking no. 134 in Healthcare sector and number 1500 in S&P 500.
Profitability by Segment |
segments |
3.45 % |
Total |
3.45 % |
|
|
Repligen achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in first quarter of 2025 to 3.89 %.
Repligen net profit margin of 3.45 % is currently ranking no. 16 in Biotechnology & Pharmaceuticals industry, ranking no. 134 in Healthcare sector and number 1500 in S&P 500.
• More on RGEN's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com